May 19th 2024
With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.
May 15th 2024
New analyses show adults aged ≥65 years old are at about 30% increased risk of hypertension when diagnosed with diabetes mellitus.
May 13th 2024
The analysis of NHANES data revealed almost 90% of adults meet the criteria for stage 1 or greater CKM syndrome, consistent from 2011-2020.
April 30th 2024
People with diabetes exhibit significantly greater odds of developing carpal tunnel syndrome compared with non-diabetic individuals.
The HCPLive Endocrinology month in review for April 2024 spotlights SURMOUNT-OSA, STEP HFpEF DM, new ACP guidelines for T2D, and more!
New Type 1 Diabetes Genetic Associations Discovered
The largest ever genome-wide association study of those with type 1 diabetes has discovered three new genetic anomalies associated with the disease.
Study Links Diabetes, Colorectal Cancer
New research has found evidence confirming that patients with diabetes have a higher risk of developing colon cancer.
Men at Higher Risk for Type 2 Diabetes than Women
Men are more prone to developing type 2 diabetes at a lower BMI than women.
Children with Both Asthma and Type 1 Diabetes Face Greater Difficulties Controlling Blood Sugar
A recent study has found that it can be very difficult for children who suffer from both type 1 diabetes and asthma to regulate their blood sugar.
Diabetes Significantly Increases Dementia Risk
Individuals with diabetes have a significantly higher risk of developing Alzheimer's disease and other forms of dementia, a new study finds.
Possible Link Indicated Between Two Diabetes Drugs and Pancreatic Cancer
Two drugs which treat type 2 diabetes could lead to a substantially increased risk of pancreatitis and pancreatic cancer.
Project Will Test Mobile Health Devices as Diabetes Control Tool
A project to be launched in Texas will test the ability of mobile health devices to help patients control diabetes.
New Class of Anti-diabetic Compounds Could Reduce Dangerous Side Effects
Researchers have created prototype drugs that have powerful anti-diabetic effects, yet are apparently free of dangerous side effects.
Increases in Fasting Plasma Glucose Greater with Atorvastatin than Pitavastatin in Patients with Type 2 Diabetes
Mobile Health Applications Show Great Promise for the Management of Chronic Illnesses
Mobile health applications show great promise for the management of chronic illnesses like diabetes.
The Days of Finger-pricking May Be Over, Thanks to an iPhone Add-on
Diabetics rejoice! Thanks to a new add-on device for smartphones, the days of finger-pricking for glucose readings may soon be over.
Newly Identified Protein May Aid Treatment of Obesity, Diabetes
According to a York University study, a recently-identified protein may help keep appetite and blood sugar down.
Insulin Pumps Susceptible to Hacking
Flaws in the software of an insulin pump could allow a hacker to remotely control the insulin levels being administered to the body.
Gaining Muscle Mass--Not Just Losing Weight--May Lower Risk of Diabetes
A new study has found that increasing muscle mass may also help lower the risk of the metabolic disease.
Should Severely Obese Children be Placed under Protective Custody?
A recent article in JAMA suggested that children at risk for morbid obesity due to poor parenting may be candidates for state protective services.
Life Expectancy Rises Among Type 1 Diabetes Patients
Life expectancy is rising rapidly among patients with type 1 diabetes thanks to new advances in medicine.
Daily dose of Aspirin could Prevent Heart Disease for Diabetes Patients
According to a recent study, individuals who have diabetes may wish to use Aspirin as a preventative strike against cardiovascular disease.
Diabetes Drug may Prevent Polycystic Ovary Syndrome
A recent study has discovered that early treatment with the diabetes drug metformin may prevent or delay the development of PCOS in young girls.
ADA 2011: Ranibizumab Improves Visual Acuity in Patients with Diabetic Macular Edema
More patients in the RIDE and RISE trials treated with the VEGF inhibitor showed improvements in vision test scores compared to patients who received placebo.
ADA 2011: Lifestyle Modifications vs. Medical Treatment in Diabetes Care
Treatment with metformin and diet and lifestyle modifications both are cost-effective means of decreasing diabetes risk and improving quality of life.
ADA 2011: New Developments in the Treatment of Type 1 Diabetes
Researchers are investigating novel ways to preserve beta cell function in type 1 diabetes patients and enhance the body's ability to produce its own insulin.
ADA 2011: Pharmacologic Options for Weight Management in Diabetic Patients
Researchers are investigating a variety of targets and pathways in the search for an effective weight-loss drug.
ADA 2011: Blood Glucose Self-monitoring Reduces Risk of CV Disease in Patients with Diabetes
Structured self-monitoring of blood glucose may result in lower levels of a key marker of cardiovascular disease risk in patient with type 2 diabetes.
ADA 2011: Solving the Challenge of Medication Adherence in Patients with Diabetes
Nonadherent patients with diabetes face severely increased risks of hospitalization and death.
ADA 2011: Assessment of Glycemic Variability and CD40 Ligand in the STAR 3 Study
Patients treated with sensor-augmented pump therapy may achieve lower glycemic variability than patients given multiple daily insulin injections.
ADA 2011: Dynamic Visual Representation of Key Data Helps Eliminate Hypoglycemia in the ICU
Real-time blood sugar and insulin infusion data displayed in the electronic medical record allows physicians to tailor treatment and get more patients to goal.
ADA 2011: Combo Treatment Increases Proportion of Diabetes Patients Achieving A1C Target
LEAD-6 trial results show improved glycemic control with weight loss and a low risk of hypoglycemia with liraglutide and exenatide.
ADA 2011: Novel SGLT2 Inhibitor Improves Glycemic Control in Patients with Diabetes
Japanese trial of TS-071 shows promise in weight loss and HbA1c reduction.
ADA 2011: How to Make the Most of the 2011 Scientific Sessions
Access information about how to follow the conference through social media and some of the key sessions worth checking out.
FDA Warns that Actos may Increase Bladder Cancer Risk
Pioglitazone, marketed as Actos, has been found to increase the risk of bladder cancer if used for more than one year.